Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Parisi

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Immunotherapy|March 23, 2018
Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 studyAlessio Cortellini, Melissa Bersanelli, Sebastiano Buti, et al.
Cancers|November 26, 2022
Conversion Strategy in Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort StudyStefano Granieri, Christian Cotsoglou, Alessandro Bonomi, et al.
Cancers|February 25, 2023
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective StudyValentina Tuninetti, Eleonora Ghisoni, Sandro Pignata, et al.
Frontiers in Oncology|March 22, 2021
Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective StudyPaolo Del Fiore, Marco Rastrelli, Luigi Dall'Olmo, et al.
Cancers|September 3, 2020
Evaluation of Prognostic Factors for Survival in Transverse Colon CancerMichela Roberto, Giulia Arrivi, Francesca Lo Bianco, et al.
Frontiers in Oncology|May 3, 2021
Corrigendum: Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective StudyPaolo Del Fiore, Marco Rastrelli, Luigi Dall'Olmo, et al.
Clinical Colorectal Cancer|January 24, 2025
Aflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter CohortJessica Lucchetti, Lorenzo Angotti, Alessandro Parisi, et al.
Scientific Reports|March 12, 2026
Clinically interpretable nomogram combining body composition and clinicopathological features for one year survival prediction in advanced solid tumorsGiulia Bruschi, Francesco Paoloni, Federica Pecci, et al.
Cancer Immunology, Immunotherapy : CII|August 28, 2023
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE studyMelissa Bersanelli, Alessio Cortellini, Alessandro Leonetti, et al.
The Oncologist|November 26, 2024
Changes in clinical presentation, management, and survival outcomes in patients affected by colorectal cancer following COVID-19 pandemicAlessandro Parisi, Riccardo Giampieri, Silvia Villani, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Immunotherapy|March 23, 2018
Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 studyAlessio Cortellini, Melissa Bersanelli, Sebastiano Buti, et al.
Cancers|November 26, 2022
Conversion Strategy in Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort StudyStefano Granieri, Christian Cotsoglou, Alessandro Bonomi, et al.
Cancers|February 25, 2023
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective StudyValentina Tuninetti, Eleonora Ghisoni, Sandro Pignata, et al.
Frontiers in Oncology|March 22, 2021
Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective StudyPaolo Del Fiore, Marco Rastrelli, Luigi Dall'Olmo, et al.
Cancers|September 3, 2020
Evaluation of Prognostic Factors for Survival in Transverse Colon CancerMichela Roberto, Giulia Arrivi, Francesca Lo Bianco, et al.
Frontiers in Oncology|May 3, 2021
Corrigendum: Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective StudyPaolo Del Fiore, Marco Rastrelli, Luigi Dall'Olmo, et al.
Clinical Colorectal Cancer|January 24, 2025
Aflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter CohortJessica Lucchetti, Lorenzo Angotti, Alessandro Parisi, et al.
Scientific Reports|March 12, 2026
Clinically interpretable nomogram combining body composition and clinicopathological features for one year survival prediction in advanced solid tumorsGiulia Bruschi, Francesco Paoloni, Federica Pecci, et al.
Cancer Immunology, Immunotherapy : CII|August 28, 2023
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE studyMelissa Bersanelli, Alessio Cortellini, Alessandro Leonetti, et al.
The Oncologist|November 26, 2024
Changes in clinical presentation, management, and survival outcomes in patients affected by colorectal cancer following COVID-19 pandemicAlessandro Parisi, Riccardo Giampieri, Silvia Villani, et al.
Pageof 11